Mitchell Capital Management CO Eli Lilly & CO Transaction History

Mitchell Capital Management CO

$549 Million
Q3 2024

A detailed history of Mitchell Capital Management CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Mitchell Capital Management CO holds 11,903 shares of LLY stock, worth $9.45 Million. This represents 1.92% of its overall portfolio holdings.

Number of Shares

11,903

Previous 12,426 4.21%

Holding current value

$9.45 Million

Previous $11.3 Million 6.27%

% of portfolio

1.92%

Previous 2.05%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $403,829 - $502,090	-523 Reduced 4.21%	11,903 $10.5 Million
Q2 2024 Aug 08, 2024	BUY	$724.87 - $909.04 $66,688 - $83,631	92 Added 0.75%	12,426 $11.3 Million
Q1 2024 May 06, 2024	SELL	$592.2 - $792.28 $140,351 - $187,770	-237 Reduced 1.89%	12,334 $9.6 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $72,476 - $85,439	138 Added 1.11%	12,571 $7.33 Million
Q3 2023 Nov 03, 2023	SELL	$434.7 - $599.3 $1.84 Million - $2.54 Million	-4,239 Reduced 25.43%	12,433 $6.68 Million
Q2 2023 Aug 08, 2023	SELL	$350.74 - $468.98 $80,319 - $107,396	-229 Reduced 1.35%	16,672 $7.82 Million
Q1 2023 May 08, 2023	BUY	$310.63 - $364.82 $2.33 Million - $2.74 Million	7,506 Added 79.89%	16,901 $5.8 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $1,607 - $1,873	-5 Reduced 0.05%	9,395 $3.44 Million
Q3 2022 Oct 28, 2022	SELL	$296.48 - $337.87 $6,522 - $7,433	-22 Reduced 0.23%	9,400 $3.04 Million
Q2 2022 Jul 29, 2022	SELL	$278.73 - $327.27 $7,804 - $9,163	-28 Reduced 0.3%	9,422 $3.06 Million
Q1 2022 Apr 29, 2022	BUY	$234.69 - $291.66 $469 - $583	2 Added 0.02%	9,450 $2.71 Million
Q4 2021 Jan 28, 2022	SELL	$224.85 - $279.04 $20,236 - $25,113	-90 Reduced 0.94%	9,448 $2.61 Million
Q3 2021 Nov 02, 2021	SELL	$221.6 - $272.71 $4,210 - $5,181	-19 Reduced 0.2%	9,538 $2.2 Million
Q2 2021 Aug 10, 2021	SELL	$180.55 - $233.54 $89,733 - $116,069	-497 Reduced 4.94%	9,557 $2.19 Million
Q1 2021 Apr 29, 2021	SELL	$164.32 - $212.72 $171,221 - $221,654	-1,042 Reduced 9.39%	10,054 $1.88 Million
Q4 2020 Feb 08, 2021	SELL	$130.46 - $172.63 $6,914 - $9,149	-53 Reduced 0.48%	11,096 $1.87 Million
Q3 2020 Nov 10, 2020	SELL	$146.22 - $169.13 $23,395 - $27,060	-160 Reduced 1.41%	11,149 $1.65 Million
Q2 2020 Jul 29, 2020	SELL	$136.42 - $164.18 $6,820 - $8,209	-50 Reduced 0.44%	11,309 $1.86 Million
Q1 2020 May 06, 2020	SELL	$119.05 - $147.35 $39,286 - $48,625	-330 Reduced 2.82%	11,359 $1.58 Million
Q4 2019 Feb 07, 2020	SELL	$106.92 - $132.43 $76,020 - $94,157	-711 Reduced 5.73%	11,689 $1.54 Million
Q3 2019 Nov 07, 2019	SELL	$106.79 - $116.16 $13,135 - $14,287	-123 Reduced 0.98%	12,400 $1.39 Million
Q2 2019 Jul 24, 2019	SELL	$110.79 - $129.32 $96,608 - $112,767	-872 Reduced 6.51%	12,523 $1.39 Million
Q1 2019 May 02, 2019	BUY	$111.31 - $131.02 $29,497 - $34,720	265 Added 2.02%	13,395 $1.74 Million
Q4 2018 Feb 08, 2019	BUY	$105.9 - $118.64 $1.39 Million - $1.56 Million	13,130 New	13,130 $1.52 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Capital Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Capital Management CO with notifications on news.

Account

Mitchell Capital Management CO Eli Lilly & CO Transaction History